Zepbound Weight Management Program in Edinburg, TX

Zepbound is a prescription medicine containing tirzepatide, given as an injection under the skin once a week.

● Adults with obesity lose weight and maintain weight loss.
● Adults with overweight and at least one weight-related health condition lose weight and maintain weight loss.
● Adults with obesity treat moderate-to-severe obstructive sleep apnea.

Zepbound is intended for ongoing treatment—not short-term or cosmetic weight loss.

Zepbound activates receptors for two hormones involved in appetite and blood sugar regulation: GIP and GLP-1. This helps reduce hunger and food intake. It also slows stomach emptying, especially early in treatment, which can help you feel full longer.

Treatment starts at a low dose and is gradually increased to improve tolerability. Your healthcare provider can assess your response, monitor side effects, and determine an appropriate dosing plan.

How is Zepbound different from other medications?

Zepbound’s main distinction is its dual-hormone action. Medicines such as Wegovy and Ozempic contain semaglutide, which targets GLP-1 alone. These medications also have different approved uses.
Zepbound and Mounjaro contain the same active ingredient, tirzepatide, but have different approved uses. Mounjaro is used to improve blood sugar control in people with type 2 diabetes, while Zepbound is approved for weight management and certain cases of obstructive sleep apnea.

Talk With Catalyst Medical Group About Your Health Goals

If you have questions about weight management, start a conversation with your Catalyst Medical Group healthcare provider. Together, you can review your health history and discuss treatment options that may support your long-term health.

If you’re considering Zepbound (tirzepatide), a healthcare professional at Catalyst Medical Group can help evaluate whether it is appropriate for your health needs and weight-management goals.

Zepbound is a prescription medication approved for long-term weight management in adults who have:

● Obesity: A body mass index (BMI) of 30 or higher.
● Overweight with a weight-related health condition: A BMI of 27 or higher, along with a condition such as high blood pressure, high cholesterol, type 2 diabetes, obstructive sleep apnea, or cardiovascular disease.

Is Zepbound right for you?

Meeting the BMI criteria does not automatically mean Zepbound is safe for you. Your clinician will review your health history, current medications, and treatment goals before recommending a medication.

You should not take Zepbound if you:

● Have a personal or family history of medullary thyroid carcinoma.
● Have Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).
● Have had a serious allergic reaction to tirzepatide or any of its ingredients.

Your evaluation should also include a discussion of any history of pancreatitis, gallbladder problems, severe stomach-emptying problems, or kidney concerns. Zepbound should not be combined with other tirzepatide-containing medications, such as Mounjaro, or with another GLP-1 receptor agonist.

If you’re considering Zepbound (tirzepatide), understanding what to expect can help you set realistic goals. Your healthcare provider at Catalyst Medical Group can help you evaluate whether prescription weight management is appropriate for your health needs.

Zepbound may start reducing appetite within the first few days to weeks, and some people notice weight loss during the first month. However, noticeable, sustained weight loss generally develops over several months. There is no guaranteed timeline or weekly amount of weight loss.

What to expect during the first few months

The usual starting dose is 2.5 mg once weekly for four weeks. This introductory dose helps your body adjust to the medication and is not a maintenance dose. Your prescriber will typically increase it to 5 mg after four weeks and may increase it further in 2.5 mg steps, at intervals of at least four weeks, depending on your response and side effects.

Because the dose increases gradually, early weight loss may be modest. You may notice reduced hunger or feel full sooner before seeing a substantial change on the scale. Weight loss often becomes more noticeable over the first three to six months and can continue beyond a year.

Regular follow-up with your prescribing clinician helps ensure that dose changes reflect your progress, tolerance, and overall health—not just the number on the scale.

Talk with Catalyst Medical Group about your weight-management goals

Zepbound can begin affecting appetite early, but meaningful weight loss usually takes months. The first month is primarily an adjustment period, and the full effect should not be judged from the starting dose alone.

If you have questions about weight management, start a conversation with your Catalyst Medical Group provider about your health history, treatment options, and realistic expectations for progress.

If your Catalyst Medical Group clinician prescribes Zepbound, knowing what to expect can help you start treatment with confidence.
Zepbound (tirzepatide) is a once-weekly prescription injection used alongside a reduced-calorie eating plan. It works on two hormone receptors, GIP and GLP-1, to help regulate appetite and food intake.

You’ll start with a low dose

The usual starting dose is 2.5 mg once weekly for four weeks. This introductory dose helps your body adjust; it is not a maintenance dose. Your prescriber will typically increase it to 5 mg weekly and may recommend additional increases after at least four weeks at each dose, depending on your response and side effects. Not everyone needs the highest dose.
Inject Zepbound under the skin of your abdomen, thigh, or upper arm, rotating injection sites. Take it on the same day each week, with or without food, and follow the instructions for your prescribed device. Ask your care team if you need help understanding how to give your injection.

Your appetite and eating habits may change

You may feel less hungry, feel full sooner, or notice fewer food cravings. Some people notice changes early, while others need more time or a higher dose. Weight loss generally develops over months—not days—and your first month’s results do not necessarily predict your longer-term response.

Smaller meals, eating slowly, and stopping when comfortably full may help you adjust. Aim for balanced nutrition, adequate protein, and regular fluids, even when your appetite is lower.

Know when to seek medical attention

Some symptoms need prompt evaluation rather than waiting for your next appointment:

● Severe or persistent abdominal pain, especially if it spreads to your back: Seek urgent medical care, as this may indicate pancreatitis.
● Upper abdominal pain with fever, jaundice, or pale stools: Seek prompt care for a possible gallbladder problem.
● Repeated vomiting, dizziness, or very little urine: Seek prompt care for possible dehydration or kidney problems.
● Trouble breathing or swelling of your face, lips, tongue, or throat: Get emergency help immediately.

Zepbound can also cause low blood sugar, particularly when taken with insulin or a sulfonylurea. Tell your prescriber if you use these medicines, as your diabetes treatment may need adjustment.

Choosing Dr. Padmini Bhadriraju, MD, for medical weight loss guidance means receiving personalized care from a board-certified internal medicine physician with extensive experience in chronic disease management and preventive healthcare. Having served patients in the Rio Grande Valley for many years, Dr. Bhadriraju understands the importance of addressing weight concerns alongside overall metabolic health. She can evaluate your medical history, current weight, BMI, existing health conditions, and treatment goals to determine whether Zepbound (tirzepatide) may be an appropriate option for you.

Dr. Bhadriraju believes that successful weight management involves more than medication alone. Her patient-centered approach emphasizes healthy lifestyle changes, nutritional guidance, and ongoing medical monitoring to support sustainable progress. For patients considering Zepbound, she can discuss eligibility, potential side effects, treatment expectations, and the importance of regular follow-ups.

At Catalyst Medical Group in Edinburg, TX, patients receive individualized weight management guidance focused on improving overall health, building healthier habits, and supporting long-term weight management goals.

For more information, contact us or book an appointment online. We are conveniently located at 5215 S McColl Rd Edinburg, TX 78539. We serve patients from Edinburg TX, McAllen TX, San Juan TX, Alamo TX, Pharr TX, Palmhurst TX, Mission TX, Alton TX and Palmview TX.